KR0153063B1 - Inhibition of food pathogens by hop acids - Google Patents
Inhibition of food pathogens by hop acidsInfo
- Publication number
- KR0153063B1 KR0153063B1 KR1019950701654A KR19957001654A KR0153063B1 KR 0153063 B1 KR0153063 B1 KR 0153063B1 KR 1019950701654 A KR1019950701654 A KR 1019950701654A KR 19957001654 A KR19957001654 A KR 19957001654A KR 0153063 B1 KR0153063 B1 KR 0153063B1
- Authority
- KR
- South Korea
- Prior art keywords
- beta
- acid
- food
- ppm
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
- A23L3/3499—Organic compounds containing oxygen with doubly-bound oxygen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/12—Preserving with acids; Acid fermentation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
- A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
- A23B4/20—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/097—Preservation
- A23C19/10—Addition of preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 호프로부터 추출된 베타-산 6 내지 50 ppm, 바람직하게는 6 내지 15 ppm을 식품중에 혼입시키므로써, 식품 병원균, 구체적으로는 리스테리아 모노사이토제니스에 의한 감염으로부터 식품을 보호하는 것에 관한 것이다.The present invention relates to the protection of food from infection by food pathogens, specifically Listeria monocytogenes, by incorporating 6-50 ppm, preferably 6-15 ppm, of beta-acid extracted from hops into the food. .
Description
[발명의 명칭][Name of invention]
호프 산에 의한 식품 병원균의 억제 방법Inhibition method of food pathogen by hop acid
[발명의 배경][Background of invention]
본 발명은 인간에게 소비되는 식품에서 리스테리아(Listeria) 및 기타 식품 병원균을 억제하기 위한, 호프(hop)로부터 추출된 베타-산의 용도에 관한 것이다.The present invention relates to the use of beta-acids extracted from hops for inhibiting Listeria and other food pathogens in food consumed by humans.
최근 연구에서는 리스테리아종 및 구체적으로 리스테리아모노사이토제니스(Listeria monocytogenes)에 의해 발생되는 인간의 리스테리아종이 다양한 형태의 식품, 구체적으로는 연질 치즈 및 파이 뿐만 아니라 햄 및 기타 포장된 육류 및 가금류 제품의 소비와 관련되어 있음을 밝혀냈다. 벨라니(S. Velani) 및 길버트(R. J. Gilbert)의 PHLS 식품 체인점에서의 16개 공공 보건 연구소에 의한 보고서인 [Listeria Monocytogenes in Prepacked Ready-To-Eat Sliced Meats, PHLS Microbiology Digest Vol. 7(1990)]를 참고한다.Recent studies have shown that Listeria monocytogenes and human Listeria monocytogenes, in particular, have been shown to affect the consumption of various types of foods, particularly soft cheeses and pies, as well as ham and other packaged meat and poultry products. Found to be relevant. Listeria Monocytogenes in Prepacked Ready-To-Eat Sliced Meats, PHLS Microbiology Digest Vol., A report by 16 public health laboratories at PHLS food chains in S. Velani and R. J. Gilbert. 7 (1990).
호프 및 이들에 관련된 산은 세균학적 억제제로서 오랫동안 인식되어 왔다. 보다 구체적으로는, 호프 산 및 수지는 그람 양성균, 예를들면 간균(Bacilli), 코리네박테리아(Corynebacteria), 쌍구균(Diplococci), 마이코박테리아(Mycobacteria), 연쇄구균(Streptococci), 유산균(Lactobacilli) 및 스트렙토마이시즈(Streptomyces)에 대해 일차적 활성이 있음을 나타내고 있다. 대부분의 출판물은 유산균에 대해 촛점을 맞추고 있는데, 이는 이 유기체가 맥주 발효에서 주 감염체이기 때문이다. 그람 음성균에 대한 활성은 보다 적게 알려져 있다. 테우버(Teuber) 및 쉬말레크(Schmalrek)의 문헌 [Arch. Mikrobiol. 94, pp. 159∼171, 1973] 및 심프슨(Simpson) 및 해몬드(Hammond)의 문헌[European Brewery Convention, 1991]은 그람 양성균에서는 유도된 세포막의 투과성으로 인해 효과가 발생하지만, 그람 음성균에서는 혈청 인지질에 의해 불활성이었음을 제시하고 있다.Hopes and their related acids have long been recognized as bacteriological inhibitors. More specifically, hop acids and resins are Gram-positive bacteria such as Bacilli, Corynebacteria, Diplococci, Mycobacteria, Streptococci, Lactobacilli and It has been shown to have primary activity against Streptomyces. Most publications focus on lactic acid bacteria, because this organism is the main infectious agent in beer fermentation. Less activity is known for Gram-negative bacteria. Teuber and Schmalrek, Arch. Mikrobiol. 94, pp. 159-171, 1973 and the Simpson and Hammond Convention (European Brewery Convention, 1991) are effective due to the permeability of cell membranes induced in Gram-positive bacteria, but inactivated by serum phospholipids in Gram-negative bacteria Presenting.
[발명의 개요][Overview of invention]
본 발명은 호프에 함유된 고미산중 베타-산이 베타-산에 의한 강한 맛이 느껴지지 않을 만한 양으로 위함한 병원균(리스테리아)에 대한 살균제로서 유용하다는 발견에 관한 것이다.The present invention relates to the discovery that beta-acids in high-mimic acids contained in hops are useful as fungicides against pathogens (listeria) for amounts not likely to be strongly tasted by beta-acids.
[발명의 상세한 설명]Detailed description of the invention
맥주 제조에서 호프의 오랜동안의 역할중 하나인 정균 작용은 무균 발효 및 포장에 의한 맥주의 근대식 제조에서는 절대적인 것이었다. 호프의 고미산 성분 및 구체적으로는 베타-산은 현재 식품에서 살균제로서 예상밖으로 유용하다고 알려지게 되었다. 호프의 성분으로서 발견된 고미산의 가장 유력한 그룹은 각각 휴물론(humulones) 및 루풀론(lupulones)으로 언급되는 알파-산 및 베타-산이다. 상기 두가지 모두는 맥주에 고미제로서 공헌하지만, 이러한 관점에서 알파-산은 베타-산보다 훨씬 더 강력하다. 또한, 호프 추출물의 제조업자는 최근 초임계 조건하에서 액체 이산화탄소를 사용하여 두개의 산 분획물로 분리시키는 기술을 개발시켰다. 작업의 부산물은 대략 61 중량%의 베타-산과 필수적으로 호프 수지로 구성되는 잔여물을 함유하는 생산물이다.The bacteriostatic action, one of Hope's long-standing roles in beer production, was absolute in the modern production of beer by aseptic fermentation and packaging. Hope's high acid component and specifically beta-acid, have now been found to be unexpectedly useful as fungicides in food. The most potent groups of high mimic acids found as components of hops are alpha- and beta-acids, referred to as huulones and lupulones, respectively. Both of these contribute to beer as a bitter, but in this respect alpha-acid is much more potent than beta-acid. In addition, manufacturers of hop extracts have recently developed a technique for separating two acid fractions using liquid carbon dioxide under supercritical conditions. The byproduct of the operation is a product containing approximately 61% by weight of beta-acid and the residue consisting essentially of the hop resin.
호프에 함유된 알파-산은 하기와 같은 일반식을 갖는다:The alpha-acids contained in the hops have the general formula:
알파-산은 초산연에 의해 침전물을 형성한다.Alpha-acids form precipitates by lead acetate.
호프에 함유된 베타-산은 하기 일반식을 갖는다:Beta-acids contained in hops have the following general formula:
베타-산은 초산연에 의해 침전물을 형성하지 않는다.Beta-acids do not form precipitates by lead acetate.
본원에서 사용되는 베타-산은 실질적으로 pH 5.2이하에서 수용액중에 불용성이지만, pH 7을 초과하면 쉽게 용해된다. 따라서, 베타-산을 통상 pH 7 내지 9.5에서 수용액으로서, 처리할 식품에 적용한다. 일반적으로, 수용액은 베타 산6 내지 100ppm 및 가장 바람직하게는 15내지 50ppm을 함유한다. 베타 산의 수용액을 스프레이로서 처리할 식품에 적용하고, 식품을 저장하기 전에 베타 산의 용액중에 침지시킬 수 있다.As used herein, beta-acid is substantially insoluble in aqueous solutions below pH 5.2, but readily dissolves above pH 7. Thus, beta-acid is usually applied as an aqueous solution at pH 7-9.5 to the food to be treated. Generally, the aqueous solution contains 6 to 100 ppm of beta acid and most preferably 15 to 50 ppm. An aqueous solution of beta acid may be applied to the food to be treated as a spray and immersed in a solution of beta acid before storing the food.
사용되는 발효 공정 및 호프의 종류에 따라서, 양조 공정시 호프를 맥아즙에 리터당 1 내지 8그램의 양으로 첨가한다. 일반적으로, 호프는 알파-산 2 내지 12 중량% 및 베타-산 1 내지 10중량%를 함유한다. 따라서 맥아즙의 베타-산 함량은 0.001 내지 0.08 중량%(10 내지 800 ppm)의 베타-산이다. 일반적으로, 본원에 사용하기 위해 베타-산을 추출하여 베타-산 50 내지 80 중량%를 함유하는 생산물로 제조하고, 희석 또는 농축시켜, 목적하는 수용액을 제조한다.Depending on the fermentation process and the type of hops used, the hops are added to the wort in an amount of 1 to 8 grams per liter during the brewing process. Generally, the hops contain 2 to 12% by weight alpha-acid and 1 to 10% by weight beta-acid. Thus the beta-acid content of wort is 0.001 to 0.08% by weight (10 to 800 ppm) of beta-acid. In general, for use herein, beta-acids are extracted to produce products containing 50-80% by weight of beta-acid, diluted or concentrated to produce the desired aqueous solution.
본 발명은 베타-산이 풍부한 이산화탄소 추출물 분획이 식품방부제로서 유용하다는 발견에 관한 것이다. 본 발명은 식품 병원균인 리스테리아 모노사이코제니스를 목표로 한다. 상기 병원균은 임의의 기타 식품 병원균보다 두배나 넘는 수인, 대략 연간 70명을 죽게하고 있다. 일반적으로, 리스테리아균 감염의 주원인은 식품 제조업자라고 믿고 있다. 이러한 사실은 리스테리아를 검출하고 억제시키는 신기술에 대한 강력한 연구를 이끌고 있다.The present invention relates to the discovery that beta-acid rich carbon dioxide extract fractions are useful as food preservatives. The present invention aims at a food pathogen, Listeria monopsychogenis. The pathogen kills approximately 70 people per year, more than twice the number of any other food pathogen. In general, it is believed that the main cause of Listeria infection is food manufacturers. This leads to powerful research into new technologies for detecting and suppressing Listeria.
리스테리아 모노사이토제니스의 성장은 베타-산 백만(ppm)당 6부의 농도로 액체 배지에서 완전히 억제된다는 사실이 현재 밝혀졌다. 본 발명자의 실험은 상기 효과가 정균적이라는 것을 나타내고 있다. 본 발명자는 또한 살모넬라 엔테리티디스(Salmonella enteritidis)(장염균), 스타필로코커스 아우레우스(Staphylococcus aureus)(포도상구균) 및 클로스트리듐 퍼프린지스(Clostridium perfringes)(웰치균)에 있어서 베타-산에 의한 성장 억제에 대해 밝혀내었다. 또한, 캄필로박투 스푸토룸 부불러스(Campylobactu sputorum bubulus), 사카로마이시즈 세레비시엑(Sccharomyces cerevisieac)(맥주효모균), 아스퍼길러스니게르(Aspergillus niger)(흑색국균), 칸디다 트로피칼리스(Candidatropicalis), 지오트리쿰 종(Geotrichum sp.), 페니실륨 그리세오펄붐(Penicillium griseofulvum) 및 푸사륨 트리신툼(Fusarium tricintum)에 있어서는 베타-산에 의해 어떠한 성장 억제도 나타나지 않았다.It has now been found that the growth of Listeria monocytogenes is completely inhibited in liquid medium at a concentration of 6 parts per million beta-acids (ppm). The experiments of the present inventors show that the effect is bacteriostatic. We also found beta-acids in Salmonella enteritidis (enterococci), Staphylococcus aureus (S. aureus) and Clostridium perfringes (Welch). Growth inhibition by In addition, Campylobactu sputorum bubulus, Sccharomyces cerevisieac (beer yeast), Aspergillus niger (black bacillus), Candida tropicalalis (Candidatropicalis) ), Geotrichum sp., Penicillium griseofulvum and Fusarium tricintum did not show any growth inhibition by beta-acid.
맛에 대한 평가는 정제된 베타-산이 15 ppm을 초과시 강한 맛을 내고, 50 ppm을 초과시 불쾌한 맛을 낸다는 것을 나타내고 있다. 따라서, 일반적으로 리스테리아에 의한 감염으로부터 보호하기 위해서는 베타-산을 식품중에 6 내지 50 ppm, 가장 바람직하게는 6 내지 15 ppm의 양(식품의 중량기준으로)으로 적용한다.The evaluation of taste indicates that the purified beta-acid has a strong taste above 15 ppm and an unpleasant taste above 50 ppm. Thus, in general, to protect against infection by Listeria, beta-acid is applied in foods in an amount of 6 to 50 ppm, most preferably 6 to 15 ppm (by weight of the food).
대개 리스테리아에 의해 감염될 수 있는 식품은 치즈, 구체적으로는 연질 치즈, 해산물 및 핫도그, 소세지, 햄, 칠면조 및 치킨을 포함하는 가공 육류를 포함하는 고형 식품이다.Foods that can usually be infected by Listeria are solid foods, including cheese, in particular soft cheeses, seafood and processed meats including hot dogs, sausages, hams, turkeys and chickens.
[실시예]EXAMPLE
[실시예 1]Example 1
베타-산 분획의 1.0g 샘플을 계량하고, 큰 시험관에 넣었다. 베타-산 분획은 롬 앤드 하스 앤드 캄파니(Rohm and Hass Company)에서 시판하는 제품이고, 초 임계 조건하에서 호프의 액체 이산화탄소 추출물에 의해 수득되는 것이었다. 베타-산 분획은 61% 베타-산을 함유하고, 잔여물은 필수적으로 호프 수지이었다. 시험관에 헥산 5ml를 첨가하고, 시험관의 내용물을 뒤흔들어 베타-산을 용해시켰다.1.0 g samples of the beta-acid fraction were weighed and placed in large test tubes. The beta-acid fraction is a product sold by the Rohm and Hass Company and was obtained by Hoff's liquid carbon dioxide extract under supercritical conditions. The beta-acid fraction contained 61% beta-acid and the residue was essentially hop resin. 5 ml of hexane was added to the test tube and the contents of the test tube were shaken to dissolve beta-acid.
1M 수성 NaOH 15ml를 시험관에 첨가하고, 시험관의 내용물을 잘 뒤흔들었다. 알칼리성 수성성을 천천히 따라부어 제거시키고 저장하였다. 또다른 1M 수성 NaOH 15ml를 시험관에 첨가하고, 시험관의 내용물을 잘 뒤흔들었다. 알칼리성 수성상을 천천히 따라부어 제거시키고, 상기 저장된 알칼리 수성상과 결합시켰다. 결합된 알칼리성 수성상 물질을 농축 염산에 의해 약 pH 1로 산성화시켰다. 이어서, 산성화된 수성상을 분리 깔때기를 사용하여 정량의 석유 에테르 125ml로 세번 추출하였다. 베타-산의 용액을 23내지 24℃에서 황산 나트륨상에서 건조시키고, 이어서 45℃에서 실험 장치 로토-백(Roto-Vac)으로 증발시켜, 오일성 잔사만이 남을 때까지 과량의 에테르를 제거시켰다. 오일을 -20℃에서 냉동기에 넣었다. 여과에 의해 단리시켜 결정을 형성시키고, 이어서 -20℃에서 에테르로부터 재결정시켰다. 사용할 때까지 베타-산을 냉동기에 저장하였다.15 ml of 1 M aqueous NaOH was added to the test tube and the contents of the test tube were shaken well. The alkaline aqueous phase was slowly poured over and removed and stored. Another 15 ml of 1M aqueous NaOH was added to the test tube and the contents of the test tube were shaken well. The alkaline aqueous phase was slowly poured off and combined with the stored alkaline aqueous phase. The combined alkaline aqueous phase material was acidified to about pH 1 with concentrated hydrochloric acid. The acidified aqueous phase was then extracted three times with 125 ml of petroleum ether using a separatory funnel. The solution of beta-acid is dried over sodium sulfate at 23 to 24 ° C. and then the experimental apparatus roto-bag at 45 ° C. (Roto-Vac ), Excess ether was removed until only oily residue remained. The oil was placed in the freezer at -20 ° C. Isolation by filtration to form crystals, which were then recrystallized from ether at -20 ° C. Beta-acid was stored in the freezer until use.
[실시예 2]Example 2
대부분의 시험관에 뇌-심장 육즙(B-H 육즙) 5ml을 넣었다. 시험관을 B-H 육즙중에 하룻밤 성장시킨 100 마이크로리터의 리스테리아 배양액으로 접종시켰다. 실시예 1에서 제조된 베타-산의 용액을 각 시험관에 첨가하여 하기 표 2에 나타낸 베타-산 농도를 갖게 하였다. 농축된 B-H 육즙 및 베타-산을 함유하는 또다른 시험관 세트를 상기제조 방법에 따라서 제조하였다. 이들 후자 시험관은 리스테리아로 접종시키지 않았다. 모든 시험관을 24시간동안 35℃에서 함께 항온처리하였다.Most test tubes contain 5 ml of brain-heart juice (B-H juice). Test tubes were inoculated with 100 microliters of Listeria culture grown overnight in B-H broth. A solution of beta-acids prepared in Example 1 was added to each test tube to give the beta-acid concentrations shown in Table 2 below. Another set of test tubes containing concentrated B-H broth and beta-acids was prepared according to the above preparation method. These latter test tubes were not inoculated with Listeria. All test tubes were incubated together at 35 ° C. for 24 hours.
상기 표에서 나타난 바와 같이, 베타-산은 약 5ppm이상의 양에서 리스테리아에 대한 효과적인 정균 활성을 갖고 있다.As shown in the table above, beta-acid has an effective bacteriostatic activity against Listeria in an amount of about 5 ppm or more.
표2에서, NG/성장에 대한 열은 접시 수에 대한 값, 또는 배지 ml당 살아있는 콜로니 수를 나타낸다. 론(lawn) 또는 TNTC 표시는 ml당 300개 이상의 콜로니를 나타낸다.In Table 2, the column for NG / growth represents the value for the number of dishes, or the number of live colonies per ml of medium. Lawn or TNTC designations represent more than 300 colonies per ml.
[실시예 3]Example 3
베타-산 100 ppm을 함유하는 용액을 하기와 같이 제조하였다.A solution containing 100 ppm of beta-acids was prepared as follows.
실시예 1의 베타-산 용액 10㎎을 45ml 멸균 시험관에 넣었다. 시험관에 95% 에틸 알콜 10ml를 첨가하여 베타-산을 용해시켰다. 생성 용액을 100ml 용량의 플라스크에 첨가하였다. 플라스크의 내용물을 8.5pH의 뮤엘러 힌튼 브로트(Mueller Hinton Broth)로 전체 100ml가 되게 하였다. 생성 용액을 다공 크기 0.45U의 여과기를 사용하여 멸균 조건하에서 여과시켰다. 여과된 베타-산 용액은ml 및 뮤엘러 힌튼 브로트 1.6 ml를 교반 막대가 정착된 멸균 125ml 진탕 플라스크에 첨가하였다. 뮤엘러 힌튼 브로트 20ml를 상기 제조된 충분량의 베타-산 용액과 함께 18개 50ml 시험관의 각각에 첨가하여 표 3에 나타낸 베타-산의 양이 되게 하였다. 모든 시험관을 충진시킨후, 2.5ml를 각 시험관으로부터 제거하여 pH를 기록하였다. 9개의 시험관을 25Ul 리스테리아 뮤엘러 힌튼 보로트(6N)로 접종시켰다. 모든 18개의 시험관을 24시간동안 35℃에서 항온처리하였다. O.D.(600nm) 및 pH를 24시간동안 항온처리한 후 기록하였다. 결과를 표3에서 나타냈다.10 mg of the beta-acid solution of Example 1 was placed in a 45 ml sterile test tube. 10 ml of 95% ethyl alcohol was added to the test tube to dissolve beta-acid. The resulting solution was added to a 100 ml flask. The contents of the flask were made up to 100 ml in total with 8.5 pH Mueller Hinton Broth. The resulting solution was filtered under sterile conditions using a filter of pore size 0.45U. The filtered beta-acid solution ml and 1.6 ml Mueller Hinton broth were added to a sterile 125 ml shake flask with a stir bar. 20 ml of Mueller Hinton broth were added to each of 18 50 ml test tubes with sufficient beta-acid solution prepared above to the amount of beta-acid shown in Table 3. After all the tubes were filled, 2.5 ml were removed from each tube to record the pH. Nine test tubes were inoculated with 25U Listeria Mueller Hinton Bolot (6N). All 18 test tubes were incubated at 35 ° C. for 24 hours. OD (600 nm) and pH were recorded after incubation for 24 hours. The results are shown in Table 3.
[실시예 4]Example 4
100 ppm 베타-산을 함유하는 용액을 하기와 같이 제조하였다:A solution containing 100 ppm beta-acids was prepared as follows:
실시예 1의 베타-산 용액 10㎎을 45ml 멸균 시험관에 넣었다. 시험관에 95% 에틸 알콜 10ml를 첨가하여 베타-산을 용해시켰다. 생성 용액을 100ml 용량의 플라스크에 첨가하였다. 플라스크의 내용물은 8.5pH의 뮤엘러 힌튼 브로트로 전체 100ml가 되게 하였다. 생성 용액을 다공 크기 0.45Um의 여과기를 사용하여 멸균 조건하에서 여과시켰다. 여과된 베타-산 용액ml 및 B-H 육즙 1.6ml를 교반 막대가 장착된 멸균 125ml 진탕 플라스크에 첨가하였다. B-H 육즙 20ml를 상기 제조된 충분량의 베타-산 용액과 함께 18개 50ml 시험관의 각각에 첨가하여 표 4에 나타낸 베타-산의 양이 되게 하였다. 모든 시험관을 충진시킨 후, 2.5ml를 각 시험관으로부터 제거하여 pH를 기록하였다. 9개의 시험관을 B-H 육즙(6N)중의 25Ul 리스테리아로 접종시켰다. 모든 18개의 시험관을 24시간동안 35℃에서 항온처리하였다. O.D(600nm) 및 pH를 24시간동안 항온처리한 후 기록하였다. 결과를 표 4에 나타냈다.10 mg of the beta-acid solution of Example 1 was placed in a 45 ml sterile test tube. 10 ml of 95% ethyl alcohol was added to the test tube to dissolve beta-acid. The resulting solution was added to a 100 ml flask. The contents of the flask were made up to 100 ml in total with 8.5 pH Mueller Hinton broth. The resulting solution was filtered under sterile conditions using a filter of pore size 0.45 Um. Filtered beta-acid solution ml and 1.6 ml of BH broth were added to a sterile 125 ml shake flask equipped with a stir bar. 20 ml of BH gravy were added to each of 18 50 ml test tubes with sufficient beta-acid solution prepared above to bring the amounts of beta-acids shown in Table 4. After all the tubes were filled, 2.5 ml were removed from each tube to record the pH. Nine test tubes were inoculated with 25 Ul Listeria in BH broth (6N). All 18 test tubes were incubated at 35 ° C. for 24 hours. OD (600 nm) and pH were recorded after incubation for 24 hours. The results are shown in Table 4.
상기 실시예에서, O.D는 일회용 카벳트(cavette)에서 잘 혼합된 육즙 2.5ml를 사용하여 600nm에서 구하였다.In this example, O.D was obtained at 600 nm using 2.5 ml of well mixed juicy in disposable cavette.
결과는 베타-산이 뮤엘러 힌튼 및 B-H 육즙 모두에 대해 리스테리아의 성장을 6 ppm 이하로 억제하는 것을 나타낸다.The results indicate that beta-acid inhibits the growth of Listeria below 6 ppm for both Mueller Hinton and B-H gravy.
pH는 베타-산의 농도에 의해 영향을 받지만, 리스테리아의 성장률과 상관이 없다. 따라서, pH는 본원에서 관찰되는 리스테리아의 성장 억제에 대해 관계하지 않는다.pH is influenced by the concentration of beta-acids, but is independent of the growth rate of Listeria. Thus, pH does not concern the inhibition of growth of Listeria as observed herein.
Claims (7)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7/969,698 | 1992-10-29 | ||
US07/969,698 US5286506A (en) | 1992-10-29 | 1992-10-29 | Inhibition of food pathogens by hop acids |
PCT/US1993/010249 WO1994009759A2 (en) | 1992-10-29 | 1993-10-26 | Inhibition of food pathogens by hop acids |
Publications (1)
Publication Number | Publication Date |
---|---|
KR0153063B1 true KR0153063B1 (en) | 1998-10-01 |
Family
ID=25515874
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950701654A KR950703933A (en) | 1992-10-29 | 1993-10-26 | INHIBITION OF FOOD PATHOGENS BY HOP ACIDS |
KR1019950701654A KR0153063B1 (en) | 1992-10-29 | 1993-10-26 | Inhibition of food pathogens by hop acids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950701654A KR950703933A (en) | 1992-10-29 | 1993-10-26 | INHIBITION OF FOOD PATHOGENS BY HOP ACIDS |
Country Status (9)
Country | Link |
---|---|
US (1) | US5286506A (en) |
EP (1) | EP0668756A1 (en) |
JP (1) | JP2731632B2 (en) |
KR (2) | KR950703933A (en) |
AU (1) | AU5411194A (en) |
CA (1) | CA2147646C (en) |
NZ (1) | NZ257479A (en) |
OA (1) | OA10146A (en) |
WO (1) | WO1994009759A2 (en) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370863A (en) * | 1992-12-16 | 1994-12-06 | Miller Brewing Company | Oral care compositions containing hop acids and method |
US5827895A (en) * | 1996-02-27 | 1998-10-27 | Regents Of The University Of Minnesota | Hexahydrolupulones useful as anticancer agents |
WO1998011883A1 (en) * | 1996-09-20 | 1998-03-26 | Regents Of The University Of Minnesota | Use of hexahydrolupulones as antibacterial agents |
AU8747498A (en) * | 1997-08-22 | 1999-03-16 | Nippon Shinyaku Co. Ltd. | Food-preservative composition |
US6251461B1 (en) * | 1997-10-10 | 2001-06-26 | S. S. Steiner, Inc. | Antimicrobial activity of hops extract against Clostridium botulinum, Clostridium difficile and Helicobacter pylori |
AU3721300A (en) * | 1999-03-05 | 2000-09-21 | Haas Hop Products, Inc. | Process for controlling micro-organisms in an aqueous process medium |
DE19909827A1 (en) | 1999-03-05 | 2000-09-07 | Betatec Hopfenprodukte Gmbh | Process for controlling microorganisms in a sugar-containing, aqueous process medium |
CA2367493A1 (en) | 1999-04-22 | 2000-11-02 | Miller Brewing Company | Method for decontaminating yeast |
US6451365B1 (en) | 2000-07-14 | 2002-09-17 | Rhodia Inc. | Antibacterial composition for control of gram positive bacteria in food applications |
CN1370055A (en) * | 1999-07-14 | 2002-09-18 | 罗狄亚公司 | Antibacterial compsn. for control of gram positive bacteria in food applications |
US6475537B1 (en) | 2000-07-27 | 2002-11-05 | Rhodia Inc. | Hops acid antibacterial compositions |
JP2003528807A (en) * | 1999-07-27 | 2003-09-30 | ローディア インコーポレイティド | Hop acid antibacterial composition |
US6547971B2 (en) | 2000-03-08 | 2003-04-15 | Hercules Incorporated | Methods of using hop acids to control organisms |
JP4669198B2 (en) * | 2000-06-21 | 2011-04-13 | 三菱化学フーズ株式会社 | Method for producing pickles and antimicrobial composition |
US6379720B1 (en) * | 2000-07-18 | 2002-04-30 | Nalco Chemical Company | Compositions containing hops extract and their use in water systems and process streams to control biological fouling |
DE60128490T8 (en) * | 2001-03-02 | 2008-05-15 | Kalsec Inc., Kalamazoo | Labiatae herb extracts and hops extracts to extend the color life and inhibit the growth of microorganisms in fresh meat, fish and poultry |
BR0208418A (en) * | 2001-04-05 | 2004-03-30 | Unilever Nv | Use of isoxantohumol and / or xantohumol, method for administering isoxantohumol and / or xantohumol to humans in need of an anti-inflammatory or anti-aging component, and, food product |
US8206753B2 (en) * | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US7901714B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
US7666449B2 (en) * | 2001-06-20 | 2010-02-23 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US7901713B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US7270835B2 (en) * | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20040219240A1 (en) * | 2001-06-20 | 2004-11-04 | Babish John G. | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20090263522A1 (en) * | 2001-10-26 | 2009-10-22 | Babish John G | Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2 |
US7279185B2 (en) * | 2001-10-26 | 2007-10-09 | Metaproteonics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
KR100993113B1 (en) * | 2002-02-14 | 2010-11-08 | 기린 홀딩스 가부시키가이샤 | Compositions and foods for improving lipid metabolism |
JP4503302B2 (en) * | 2002-02-14 | 2010-07-14 | キリンホールディングス株式会社 | Lipid metabolism improving composition and food |
CN100387255C (en) * | 2002-05-17 | 2008-05-14 | S·S·斯坦纳公司 | Application for hop acids as anti-microbial agents |
US20030228814A1 (en) * | 2002-06-07 | 2003-12-11 | Barney Michael C. | Antibacterial packaging material including hop acids |
US7247330B2 (en) * | 2002-07-23 | 2007-07-24 | Kraft Foods Holdings, Inc. | Method for controlling microbial contamination of a vacuum-sealed food product |
US20040146619A1 (en) * | 2002-09-19 | 2004-07-29 | Maye John Paul | Hop acids as an antimicrobial agent for use in food processing facility |
AU2003278940B2 (en) * | 2002-09-23 | 2010-06-24 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
NZ539642A (en) * | 2002-10-21 | 2007-01-26 | Metaproteomics Llc | Compositions containing extracts from hops in combination with a second component for treating inflammatory response |
US7354613B2 (en) * | 2002-12-23 | 2008-04-08 | Danisco A/S | Method for treating processed food products |
ES2221550B1 (en) * | 2003-02-10 | 2006-01-01 | Viscofan Sa | ANTIMICROBIAL WRAPPING. |
US20040175480A1 (en) * | 2003-03-03 | 2004-09-09 | Kraft Foods Holdings, Inc. | Hop beta acid compositions for use in food products |
US7001632B2 (en) * | 2003-03-03 | 2006-02-21 | Kraft Foods Holdings, Inc. | Anti-listeria compositions for use in food products |
CA2526804A1 (en) * | 2003-05-22 | 2005-05-06 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
WO2005009137A1 (en) * | 2003-07-21 | 2005-02-03 | Danisco Usa Inc. | Improved yield and shelf life for meats |
DK1722635T3 (en) | 2004-02-23 | 2016-01-11 | Sss Acquisition Llc | Feed containing hop acid and its use as a supplement in animal feed |
US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
US20050192356A1 (en) * | 2004-02-27 | 2005-09-01 | Babish John G. | Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
EP1799054B1 (en) * | 2004-10-04 | 2016-07-27 | Miller Brewing International, Inc. | Use of hop acids in fruit juices, fruit juice concentrates and other beverages to inhibit alicyclobacillus bacteria |
US20070031543A1 (en) * | 2005-08-06 | 2007-02-08 | Phresh Technologies, Llc | Edible anti-microbial food coating materials |
US20080248131A1 (en) * | 2005-08-09 | 2008-10-09 | Metaproteomics, Llc | Protein Kinase Modulation by Hops and Acacia Products |
US20070154576A1 (en) * | 2005-12-09 | 2007-07-05 | Tripp Matthew L | Protein kinase modulation by hops and Acacia products |
AU2007235519A1 (en) * | 2006-03-29 | 2007-10-18 | Haas, John I. | Antimicrobial compositions comprising hop acid alkali salts and uses thereof |
US7767234B2 (en) * | 2006-03-31 | 2010-08-03 | John I. Haas, Inc. | Compositions and methods for controlling a honey bee parasitic mite |
WO2007149481A2 (en) * | 2006-06-20 | 2007-12-27 | Metaproteomics, Llc | Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
US20080051466A1 (en) * | 2006-06-20 | 2008-02-28 | Metaproteomics, Llc | Isoalpha acid based protein kinase modulation cancer treatment |
EP1969934A1 (en) * | 2007-03-12 | 2008-09-17 | Bayer CropScience AG | 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides |
WO2008115783A1 (en) * | 2007-03-19 | 2008-09-25 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
AU2008251756B2 (en) * | 2007-05-11 | 2013-06-06 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
JP2011506464A (en) * | 2007-12-10 | 2011-03-03 | メタプロテオミクス, エルエルシー | Replacement 1,3-cyclopentadione multitarget protein kinase modulators of cancer, angiogenesis and their associated inflammatory pathways |
WO2009099646A1 (en) * | 2008-02-08 | 2009-08-13 | Haas, John, I. | Compositions and methods for arachnid control |
CN102066303A (en) * | 2008-04-02 | 2011-05-18 | 麦特普罗泰欧米克斯有限公司 | Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions |
AU2009278419B2 (en) | 2008-08-04 | 2015-01-15 | Mitsubishi Chemical Corporation | Antibacterial agent and disinfecting method |
JP5554908B2 (en) * | 2008-08-06 | 2014-07-23 | 三菱化学フーズ株式会社 | Antibacterial agent and antibacterial method |
AR080194A1 (en) * | 2010-02-17 | 2012-03-21 | Dsm Ip Assets Bv | LIQUID ANTIMICROBIAL COMPOSITIONS |
US20110223642A1 (en) * | 2010-03-11 | 2011-09-15 | John Paul Maye | Method for inhibiting bacteria growth during ethanol fermentation |
CA2897371C (en) | 2013-01-07 | 2022-08-30 | John I. Haas, Inc. | Compositions and methods for controlling a honey bee parasitic mite infestation |
EP2777395A1 (en) | 2013-03-14 | 2014-09-17 | S.S. Steiner, Inc. | Plant wash |
WO2015136366A1 (en) | 2014-03-14 | 2015-09-17 | Solenis Technologies, L.P. | Organic acid antimicrobial compositions |
US20160081354A1 (en) * | 2014-09-18 | 2016-03-24 | Solenis Technologies, L.P. | Method for treatment of microorganisms during propagation, conditioning and fermentation using hops acid extracts and nisin |
BE1025456B1 (en) * | 2017-08-08 | 2019-03-11 | Anheuser-Busch Inbev S.A. | 'STRONG' Flavored DRINK COMPONENT, USE THEREOF AND METHOD FOR PREPARING SUCH DRINK COMPONENT |
CA3043388A1 (en) | 2018-05-14 | 2019-11-14 | John I. Hass, Inc. | Compositions and methods for controlling a honey bee parasitic mite infestation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2550255A (en) * | 1946-04-05 | 1951-04-24 | Swift & Co | Preservation of food products |
US4170638A (en) * | 1976-11-05 | 1979-10-09 | S. S. Steiner, Inc. | Method for producing a deodorant |
-
1992
- 1992-10-29 US US07/969,698 patent/US5286506A/en not_active Expired - Fee Related
-
1993
- 1993-10-26 EP EP93924415A patent/EP0668756A1/en not_active Ceased
- 1993-10-26 WO PCT/US1993/010249 patent/WO1994009759A2/en not_active Application Discontinuation
- 1993-10-26 KR KR1019950701654A patent/KR950703933A/en not_active IP Right Cessation
- 1993-10-26 AU AU54111/94A patent/AU5411194A/en not_active Abandoned
- 1993-10-26 KR KR1019950701654A patent/KR0153063B1/en active
- 1993-10-26 CA CA002147646A patent/CA2147646C/en not_active Expired - Fee Related
- 1993-10-26 JP JP6511249A patent/JP2731632B2/en not_active Expired - Lifetime
- 1993-10-26 NZ NZ257479A patent/NZ257479A/en unknown
-
1995
- 1995-04-28 OA OA60648A patent/OA10146A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08502887A (en) | 1996-04-02 |
AU5411194A (en) | 1994-05-24 |
NZ257479A (en) | 1995-12-21 |
JP2731632B2 (en) | 1998-03-25 |
WO1994009759A3 (en) | 1994-08-04 |
OA10146A (en) | 1996-12-18 |
WO1994009759A2 (en) | 1994-05-11 |
EP0668756A1 (en) | 1995-08-30 |
KR950703933A (en) | 1995-11-17 |
CA2147646A1 (en) | 1994-05-11 |
CA2147646C (en) | 1998-11-17 |
US5286506A (en) | 1994-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0153063B1 (en) | Inhibition of food pathogens by hop acids | |
Davidson et al. | Natamycin | |
US5455038A (en) | Method of inhibiting listeria | |
Azzouz et al. | Comparative antimycotic effects of selected herbs, spices, plant components and commercial antifungal agents | |
Lee et al. | Control of Clostridium botulinum and Staphylococcus aureus in semi-preserved meat products | |
JPH05320017A (en) | Composition having improved antibacteria property and method for suppressing propagation of micro-organism such as listeria bacteria by using said composition | |
JP2022023116A (en) | Anti-microbial agent comprising xanthohumol and the use thereof in food products | |
US4525480A (en) | Composition of matter containing cinnamaldehyde and parabens | |
CA2281102A1 (en) | Stabilization of cooked meat compositions using whey from nisin-producing cultures | |
JP4143294B2 (en) | Disinfectant composition | |
Kramer et al. | Inhibition of Listeria monocytogenes on bologna by a beta acid rich hop extract | |
JP2003520608A (en) | Quaternary ammonium compound concentration, non-foaming solution and method of use thereof | |
US20110177229A1 (en) | Food preservatives | |
EP0463284B1 (en) | Method and composition for extending the shelf life of meats | |
US10602749B2 (en) | Foodstuff preserving composition and use thereof | |
US3937814A (en) | Compositions for safe extension of storage life of foods | |
CN109566719B (en) | Method for auxiliary fresh-keeping of meat by using subcritical solvent | |
AU2004200429B2 (en) | Antimicrobial casing | |
US20090111894A1 (en) | Method of Preventing Microbial Growth | |
RU2725687C2 (en) | Composition and methods for controlling proliferation of pathogens and microorganisms which cause spoilage in systems with high humidity and low content of sodium salts | |
CN109699879A (en) | Application of the plant-derived compound preservative of food-grade in meat products | |
JPH07250658A (en) | Antimicrobial agent | |
EP0453972B1 (en) | Use of lanthionines for control of post-processing contamination in food | |
JP3066891B2 (en) | Food preservatives | |
Shen | Control of Foodborne Pathogens by Hops Beta Acids in Food Systems |